 | • レポートコード：QYR2104Z1799 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、うつ病治療用療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、治療装置）、用途別市場規模（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・うつ病治療用療法の市場動向 ・企業の競争状況、市場シェア ・うつ病治療用療法の種類別市場規模（医薬品、治療装置） ・うつ病治療用療法の用途別市場規模（季節性情動障害（SAD）、大うつ病、気分変調性障害、産後うつ病、非定型うつ病、精神病性うつ病、その他） ・うつ病治療用療法の北米市場規模2016-2027（アメリカ、カナダ） ・うつ病治療用療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・うつ病治療用療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・うつ病治療用療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・うつ病治療用療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Teva Pharmaceutical、Johnson and Johnson、Merck、Eli Lily、Novartis、Sanofi、AstraZeneca、Allergan、Mayo Clinic、Bristol-Myers Squibb、Takeda、Brainsway、Lundbeck、NeuroStar、Otsuka、VistaGen Therapeutics、Silver Oak Health、NeuroSigma） ・結論 |
Market Analysis and Insights: Global Depression Treatment Therapy Market
The global Depression Treatment Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Depression Treatment Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Depression Treatment Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Depression Treatment Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Depression Treatment Therapy market.
Global Depression Treatment Therapy Scope and Market Size
Depression Treatment Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Depression Treatment Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drugs
Treatment device
Segment by Application
Seasonal affective disorder (SAD)
Major depression
Dysthymia disorder
Postpartum depression
Atypical depression
Psychotic depression
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Teva Pharmaceutical
Johnson and Johnson
Merck
Eli Lily
Novartis
Sanofi
AstraZeneca
Allergan
Merck
Eli Lily
Takeda
Brainsway
Lundbeck
NeuroStar
Otsuka
VistaGen Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depression Treatment Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Treatment device
1.3 Market by Application
1.3.1 Global Depression Treatment Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Seasonal affective disorder (SAD)
1.3.3 Major depression
1.3.4 Dysthymia disorder
1.3.5 Postpartum depression
1.3.6 Atypical depression
1.3.7 Psychotic depression
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Depression Treatment Therapy Market Perspective (2016-2027)
2.2 Depression Treatment Therapy Growth Trends by Regions
2.2.1 Depression Treatment Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Depression Treatment Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Depression Treatment Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Depression Treatment Therapy Industry Dynamic
2.3.1 Depression Treatment Therapy Market Trends
2.3.2 Depression Treatment Therapy Market Drivers
2.3.3 Depression Treatment Therapy Market Challenges
2.3.4 Depression Treatment Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Depression Treatment Therapy Players by Revenue
3.1.1 Global Top Depression Treatment Therapy Players by Revenue (2016-2021)
3.1.2 Global Depression Treatment Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Depression Treatment Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Depression Treatment Therapy Revenue
3.4 Global Depression Treatment Therapy Market Concentration Ratio
3.4.1 Global Depression Treatment Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depression Treatment Therapy Revenue in 2020
3.5 Depression Treatment Therapy Key Players Head office and Area Served
3.6 Key Players Depression Treatment Therapy Product Solution and Service
3.7 Date of Enter into Depression Treatment Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Depression Treatment Therapy Breakdown Data by Type
4.1 Global Depression Treatment Therapy Historic Market Size by Type (2016-2021)
4.2 Global Depression Treatment Therapy Forecasted Market Size by Type (2022-2027)
5 Depression Treatment Therapy Breakdown Data by Application
5.1 Global Depression Treatment Therapy Historic Market Size by Application (2016-2021)
5.2 Global Depression Treatment Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Depression Treatment Therapy Market Size (2016-2027)
6.2 North America Depression Treatment Therapy Market Size by Type
6.2.1 North America Depression Treatment Therapy Market Size by Type (2016-2021)
6.2.2 North America Depression Treatment Therapy Market Size by Type (2022-2027)
6.2.3 North America Depression Treatment Therapy Market Size by Type (2016-2027)
6.3 North America Depression Treatment Therapy Market Size by Application
6.3.1 North America Depression Treatment Therapy Market Size by Application (2016-2021)
6.3.2 North America Depression Treatment Therapy Market Size by Application (2022-2027)
6.3.3 North America Depression Treatment Therapy Market Size by Application (2016-2027)
6.4 North America Depression Treatment Therapy Market Size by Country
6.4.1 North America Depression Treatment Therapy Market Size by Country (2016-2021)
6.4.2 North America Depression Treatment Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Depression Treatment Therapy Market Size (2016-2027)
7.2 Europe Depression Treatment Therapy Market Size by Type
7.2.1 Europe Depression Treatment Therapy Market Size by Type (2016-2021)
7.2.2 Europe Depression Treatment Therapy Market Size by Type (2022-2027)
7.2.3 Europe Depression Treatment Therapy Market Size by Type (2016-2027)
7.3 Europe Depression Treatment Therapy Market Size by Application
7.3.1 Europe Depression Treatment Therapy Market Size by Application (2016-2021)
7.3.2 Europe Depression Treatment Therapy Market Size by Application (2022-2027)
7.3.3 Europe Depression Treatment Therapy Market Size by Application (2016-2027)
7.4 Europe Depression Treatment Therapy Market Size by Country
7.4.1 Europe Depression Treatment Therapy Market Size by Country (2016-2021)
7.4.2 Europe Depression Treatment Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Depression Treatment Therapy Market Size (2016-2027)
8.2 Asia-Pacific Depression Treatment Therapy Market Size by Type
8.2.1 Asia-Pacific Depression Treatment Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Depression Treatment Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Depression Treatment Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Depression Treatment Therapy Market Size by Application
8.3.1 Asia-Pacific Depression Treatment Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Depression Treatment Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Depression Treatment Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Depression Treatment Therapy Market Size by Region
8.4.1 Asia-Pacific Depression Treatment Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Depression Treatment Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Depression Treatment Therapy Market Size (2016-2027)
9.2 Latin America Depression Treatment Therapy Market Size by Type
9.2.1 Latin America Depression Treatment Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Depression Treatment Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Depression Treatment Therapy Market Size by Type (2016-2027)
9.3 Latin America Depression Treatment Therapy Market Size by Application
9.3.1 Latin America Depression Treatment Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Depression Treatment Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Depression Treatment Therapy Market Size by Application (2016-2027)
9.4 Latin America Depression Treatment Therapy Market Size by Country
9.4.1 Latin America Depression Treatment Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Depression Treatment Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Depression Treatment Therapy Market Size (2016-2027)
10.2 Middle East & Africa Depression Treatment Therapy Market Size by Type
10.2.1 Middle East & Africa Depression Treatment Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Depression Treatment Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Depression Treatment Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Depression Treatment Therapy Market Size by Application
10.3.1 Middle East & Africa Depression Treatment Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Depression Treatment Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Depression Treatment Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Depression Treatment Therapy Market Size by Country
10.4.1 Middle East & Africa Depression Treatment Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Depression Treatment Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Depression Treatment Therapy Introduction
11.1.4 Pfizer Revenue in Depression Treatment Therapy Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Teva Pharmaceutical
11.2.1 Teva Pharmaceutical Company Details
11.2.2 Teva Pharmaceutical Business Overview
11.2.3 Teva Pharmaceutical Depression Treatment Therapy Introduction
11.2.4 Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2016-2021)
11.2.5 Teva Pharmaceutical Recent Development
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Company Details
11.3.2 Johnson and Johnson Business Overview
11.3.3 Johnson and Johnson Depression Treatment Therapy Introduction
11.3.4 Johnson and Johnson Revenue in Depression Treatment Therapy Business (2016-2021)
11.3.5 Johnson and Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Depression Treatment Therapy Introduction
11.4.4 Merck Revenue in Depression Treatment Therapy Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Eli Lily
11.5.1 Eli Lily Company Details
11.5.2 Eli Lily Business Overview
11.5.3 Eli Lily Depression Treatment Therapy Introduction
11.5.4 Eli Lily Revenue in Depression Treatment Therapy Business (2016-2021)
11.5.5 Eli Lily Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Depression Treatment Therapy Introduction
11.6.4 Novartis Revenue in Depression Treatment Therapy Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Depression Treatment Therapy Introduction
11.7.4 Sanofi Revenue in Depression Treatment Therapy Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Depression Treatment Therapy Introduction
11.8.4 AstraZeneca Revenue in Depression Treatment Therapy Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Allergan
11.9.1 Allergan Company Details
11.9.2 Allergan Business Overview
11.9.3 Allergan Depression Treatment Therapy Introduction
11.9.4 Allergan Revenue in Depression Treatment Therapy Business (2016-2021)
11.9.5 Allergan Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Details
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic Depression Treatment Therapy Introduction
11.10.4 Mayo Clinic Revenue in Depression Treatment Therapy Business (2016-2021)
11.10.5 Mayo Clinic Recent Development
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Depression Treatment Therapy Introduction
11.11.4 Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2016-2021)
11.11.5 Bristol-Myers Squibb Recent Development
11.12 Takeda
11.12.1 Takeda Company Details
11.12.2 Takeda Business Overview
11.12.3 Takeda Depression Treatment Therapy Introduction
11.12.4 Takeda Revenue in Depression Treatment Therapy Business (2016-2021)
11.12.5 Takeda Recent Development
11.13 Brainsway
11.13.1 Brainsway Company Details
11.13.2 Brainsway Business Overview
11.13.3 Brainsway Depression Treatment Therapy Introduction
11.13.4 Brainsway Revenue in Depression Treatment Therapy Business (2016-2021)
11.13.5 Brainsway Recent Development
11.14 Lundbeck
11.14.1 Lundbeck Company Details
11.14.2 Lundbeck Business Overview
11.14.3 Lundbeck Depression Treatment Therapy Introduction
11.14.4 Lundbeck Revenue in Depression Treatment Therapy Business (2016-2021)
11.14.5 Lundbeck Recent Development
11.15 NeuroStar
11.15.1 NeuroStar Company Details
11.15.2 NeuroStar Business Overview
11.15.3 NeuroStar Depression Treatment Therapy Introduction
11.15.4 NeuroStar Revenue in Depression Treatment Therapy Business (2016-2021)
11.15.5 NeuroStar Recent Development
11.16 Otsuka
11.16.1 Otsuka Company Details
11.16.2 Otsuka Business Overview
11.16.3 Otsuka Depression Treatment Therapy Introduction
11.16.4 Otsuka Revenue in Depression Treatment Therapy Business (2016-2021)
11.16.5 Otsuka Recent Development
11.17 VistaGen Therapeutics
11.17.1 VistaGen Therapeutics Company Details
11.17.2 VistaGen Therapeutics Business Overview
11.17.3 VistaGen Therapeutics Depression Treatment Therapy Introduction
11.17.4 VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2016-2021)
11.17.5 VistaGen Therapeutics Recent Development
11.18 Silver Oak Health
11.18.1 Silver Oak Health Company Details
11.18.2 Silver Oak Health Business Overview
11.18.3 Silver Oak Health Depression Treatment Therapy Introduction
11.18.4 Silver Oak Health Revenue in Depression Treatment Therapy Business (2016-2021)
11.18.5 Silver Oak Health Recent Development
11.18 NeuroSigma
.1 NeuroSigma Company Details
.2 NeuroSigma Business Overview
.3 NeuroSigma Depression Treatment Therapy Introduction
.4 NeuroSigma Revenue in Depression Treatment Therapy Business (2016-2021)
.5 NeuroSigma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Depression Treatment Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Treatment device
Table 4. Global Depression Treatment Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Depression Treatment Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Depression Treatment Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Depression Treatment Therapy Market Share by Regions (2016-2021)
Table 8. Global Depression Treatment Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Depression Treatment Therapy Market Share by Regions (2022-2027)
Table 10. Depression Treatment Therapy Market Trends
Table 11. Depression Treatment Therapy Market Drivers
Table 12. Depression Treatment Therapy Market Challenges
Table 13. Depression Treatment Therapy Market Restraints
Table 14. Global Depression Treatment Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Depression Treatment Therapy Market Share by Players (2016-2021)
Table 16. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Treatment Therapy as of 2020)
Table 17. Ranking of Global Top Depression Treatment Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Depression Treatment Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Depression Treatment Therapy Product Solution and Service
Table 21. Date of Enter into Depression Treatment Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Depression Treatment Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Depression Treatment Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Depression Treatment Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Depression Treatment Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Depression Treatment Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Depression Treatment Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Depression Treatment Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Depression Treatment Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Depression Treatment Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Depression Treatment Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Depression Treatment Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Depression Treatment Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Depression Treatment Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Depression Treatment Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Depression Treatment Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Depression Treatment Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Depression Treatment Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Depression Treatment Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Depression Treatment Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Depression Treatment Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Depression Treatment Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Depression Treatment Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Depression Treatment Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Depression Treatment Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Depression Treatment Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Depression Treatment Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Depression Treatment Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Depression Treatment Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Depression Treatment Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Depression Treatment Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Depression Treatment Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Depression Treatment Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Depression Treatment Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Depression Treatment Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Depression Treatment Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Depression Treatment Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Depression Treatment Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Depression Treatment Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Depression Treatment Therapy Product
Table 64. Pfizer Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Teva Pharmaceutical Company Details
Table 67. Teva Pharmaceutical Business Overview
Table 68. Teva Pharmaceutical Depression Treatment Therapy Product
Table 69. Teva Pharmaceutical Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 70. Teva Pharmaceutical Recent Development
Table 71. Johnson and Johnson Company Details
Table 72. Johnson and Johnson Business Overview
Table 73. Johnson and Johnson Depression Treatment Therapy Product
Table 74. Johnson and Johnson Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 75. Johnson and Johnson Recent Development
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Depression Treatment Therapy Product
Table 79. Merck Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 80. Merck Recent Development
Table 81. Eli Lily Company Details
Table 82. Eli Lily Business Overview
Table 83. Eli Lily Depression Treatment Therapy Product
Table 84. Eli Lily Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 85. Eli Lily Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Depression Treatment Therapy Product
Table 89. Novartis Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Depression Treatment Therapy Product
Table 94. Sanofi Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. Allergan Company Details
Table 101. Allergan Business Overview
Table 102. Allergan Depression Treatment Therapy Product
Table 103. Allergan Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 104. Allergan Recent Development
Table 105. Mayo Clinic Company Details
Table 106. Mayo Clinic Business Overview
Table 107. Mayo Clinic Depression Treatment Therapy Product
Table 108. Mayo Clinic Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 109. Mayo Clinic Recent Development
Table 110. Bristol-Myers Squibb Company Details
Table 111. Bristol-Myers Squibb Business Overview
Table 112. Bristol-Myers Squibb Depression Treatment Therapy Product
Table 113. Bristol-Myers Squibb Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Takeda Company Details
Table 116. Takeda Business Overview
Table 117. Takeda Depression Treatment Therapy Product
Table 118. Takeda Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 119. Takeda Recent Development
Table 120. Brainsway Company Details
Table 121. Brainsway Business Overview
Table 122. Brainsway Depression Treatment Therapy Product
Table 123. Brainsway Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 124. Brainsway Recent Development
Table 125. Lundbeck Company Details
Table 126. Lundbeck Business Overview
Table 127. Lundbeck Depression Treatment Therapy Product
Table 128. Lundbeck Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 129. Lundbeck Recent Development
Table 130. NeuroStar Company Details
Table 131. NeuroStar Business Overview
Table 132. NeuroStar Depression Treatment Therapy Product
Table 133. NeuroStar Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 134. NeuroStar Recent Development
Table 135. Otsuka Company Details
Table 136. Otsuka Business Overview
Table 137. Otsuka Depression Treatment Therapy Product
Table 138. Otsuka Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 139. Otsuka Recent Development
Table 140. VistaGen Therapeutics Company Details
Table 141. VistaGen Therapeutics Business Overview
Table 142. VistaGen Therapeutics Depression Treatment Therapy Product
Table 143. VistaGen Therapeutics Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 144. VistaGen Therapeutics Recent Development
Table 145. Silver Oak Health Company Details
Table 146. Silver Oak Health Business Overview
Table 147. Silver Oak Health Depression Treatment Therapy Product
Table 148. Silver Oak Health Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 149. Silver Oak Health Recent Development
Table 150. NeuroSigma Company Details
Table 151. NeuroSigma Business Overview
Table 152. NeuroSigma Depression Treatment Therapy Product
Table 153. NeuroSigma Revenue in Depression Treatment Therapy Business (2016-2021) & (US$ Million)
Table 154. NeuroSigma Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Depression Treatment Therapy Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Treatment device Features
Figure 4. Global Depression Treatment Therapy Market Share by Application: 2020 VS 2027
Figure 5. Seasonal affective disorder (SAD) Case Studies
Figure 6. Major depression Case Studies
Figure 7. Dysthymia disorder Case Studies
Figure 8. Postpartum depression Case Studies
Figure 9. Atypical depression Case Studies
Figure 10. Psychotic depression Case Studies
Figure 11. Other Case Studies
Figure 12. Depression Treatment Therapy Report Years Considered
Figure 13. Global Depression Treatment Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Depression Treatment Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Depression Treatment Therapy Market Share by Regions: 2020 VS 2027
Figure 16. Global Depression Treatment Therapy Market Share by Regions (2022-2027)
Figure 17. Global Depression Treatment Therapy Market Share by Players in 2020
Figure 18. Global Top Depression Treatment Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depression Treatment Therapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Depression Treatment Therapy Revenue in 2020
Figure 20. Global Depression Treatment Therapy Revenue Market Share by Type (2016-2021)
Figure 21. Global Depression Treatment Therapy Revenue Market Share by Type (2022-2027)
Figure 22. North America Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Depression Treatment Therapy Market Share by Type (2016-2027)
Figure 24. North America Depression Treatment Therapy Market Share by Application (2016-2027)
Figure 25. North America Depression Treatment Therapy Market Share by Country (2016-2027)
Figure 26. United States Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Depression Treatment Therapy Market Share by Type (2016-2027)
Figure 30. Europe Depression Treatment Therapy Market Share by Application (2016-2027)
Figure 31. Europe Depression Treatment Therapy Market Share by Country (2016-2027)
Figure 32. Germany Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Depression Treatment Therapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Depression Treatment Therapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Depression Treatment Therapy Market Share by Region (2016-2027)
Figure 42. China Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Depression Treatment Therapy Market Share by Type (2016-2027)
Figure 50. Latin America Depression Treatment Therapy Market Share by Application (2016-2027)
Figure 51. Latin America Depression Treatment Therapy Market Share by Country (2016-2027)
Figure 52. Mexico Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Depression Treatment Therapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Depression Treatment Therapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Depression Treatment Therapy Market Share by Country (2016-2027)
Figure 58. Turkey Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Depression Treatment Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Pfizer Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 63. Johnson and Johnson Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 65. Eli Lily Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 69. Allergan Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 70. Mayo Clinic Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 72. Takeda Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 73. Brainsway Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 74. Lundbeck Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 75. NeuroStar Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 76. Otsuka Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 77. VistaGen Therapeutics Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 78. Silver Oak Health Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 79. NeuroSigma Revenue Growth Rate in Depression Treatment Therapy Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の産後うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…- 世界の産後うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 世界のうつ病治療薬市場規模・現状・予測（2021年-2027年） Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease y…
- 世界の季節性情動障害治療市場規模・現状・予測（2021年-2027年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…